<DOC>
	<DOCNO>NCT02027610</DOCNO>
	<brief_summary>Vitamin A deficiency ( VAD ) increase risk death infection infant young child . The World Health Organization ( WHO ) recommend high-dose vitamin A supplementation ( VAS ) 6-59 month age reduce risk death country VAD common . Such country include Bangladesh , study conduct . While provide VAS 6 month recommend , provide VAS birth may also decrease risk death since newborn infant also risk VAD . VAS presumably reduce infant mortality improve immune response infection immunization . Vitamin A particularly affect development function T cell , develop thymus key component memory response infection immunization . Vitamin A important development important class T cell , regulatory T-cells , intestine . Regulatory T-cells prevent over-reaction immune system substances immune system might otherwise treat harmful food healthy bacteria intestine . VAD could disrupt normal colonization infant 's intestinal tract cause condition call `` dysbiosis '' abnormal bacteria flourish adversely affect infant 's immune system . Dysbiosis may disrupt immune response injectable oral vaccine . VAS birth may prevent dysbiosis thus improve immune function , response vaccine , child survival . The investigator recently complete intervention trial Bangladeshi infant ( NCT01583972 ) examine effect VAS birth immune function response vaccine administer birth 14 wk age . The present study recruit infant complete NCT01583972 12 24 age determine VAS birth affect response vaccine measure second year life . The investigator examine effect VAS birth gut microbiota measure early infancy second year life , explore association gut microbiota vaccine response . Mothers study infant participate study breast milk oligosaccharide content strongly affect gut microbiota composition `` secretor status '' mother , determine maternal FUT2 genotype , strongly affect breast milk oligosaccharide content .</brief_summary>
	<brief_title>Vitamin A , Stool Microbiota Vaccine Response Bangladeshi Infants</brief_title>
	<detailed_description>Hypotheses Specific Aims The investigator test hypothesis VAS birth ( 1 ) improve production new T cell 1-2 yr age ; ( 2 ) improve T-cell memory response 1-2 yr age vaccine give early infancy ( birth - 14 wk ) ; ( 3 ) alter intestinal colonization early infancy ( 6 , 11 15 wk ) 1-2 yr age increase Bifidobacterium healthy bacteria decrease Proteobacteria harmful bacteria . Because `` secretor status '' mother affect carbohydrate content breastmilk , turn affect Bifidobacterium growth infant gut , `` secretor status '' mother determine . Furthermore difference composition intestinal bacteria associate great immunologic response oral systemic vaccine . Specific Aim 1 : Determine VAS placebo birth affect blood concentration thymic output na√Øve T-cells 1-2 yr age . Specific Aim 2 : Determine VAS placebo birth affect T-cell mediate response 1-2 yr age vaccine give early infancy , include serum intestinal antibody level , vaccine-specific proliferative response T cell cytokine production T cell . Specific Aim 3 : Determine VAS placebo birth affect relative abundance healthy intestinal bacteria common harmful bacteria feces 6 , 11 , 15 wk age 1-2 yr age determine relative abundance bacteria correlate vaccine response shortly vaccination ( 6 , 11 , 15 wk ) later infancy ( 1-2 yr ) . As part Aim 3 `` secretor status '' genotype ( FUT2 gene ) mother determine cheek swab DNA sample .</detailed_description>
	<mesh_term>Vitamin A Deficiency</mesh_term>
	<mesh_term>Night Blindness</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<criteria>infant : completion NCT01583972 mother : mother study infant</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Infant</keyword>
	<keyword>Bangladesh</keyword>
	<keyword>vitamin A</keyword>
	<keyword>microbiota</keyword>
	<keyword>vaccine</keyword>
	<keyword>immunity</keyword>
</DOC>